Merdury Biopharmaceutical Corporation (TPEX:6932)
8.89
+0.12 (1.37%)
At close: Feb 26, 2026
-45.46% (1Y)
| Market Cap | 3.72B |
| Revenue (ttm) | 246.00K |
| Net Income (ttm) | -70.59M |
| Shares Out | 418.44M |
| EPS (ttm) | -0.17 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 465,901 |
| Average Volume | 914,370 |
| Open | 8.77 |
| Previous Close | 8.77 |
| Day's Range | 8.75 - 9.00 |
| 52-Week Range | 4.95 - 17.45 |
| Beta | -2.63 |
| RSI | 50.21 |
| Earnings Date | Apr 2, 2026 |